• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Building a 3D model of ovarian cancer

Bioengineer by Bioengineer
March 2, 2014
in Cancer
Reading Time: 2 mins read
1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The European Research Council (ERC) has awarded researchers at Barts Cancer Institute, Queen Mary University of London, a €2.43million grant for a project that aims to revolutionise the field of cancer cell research: using bioengineering techniques to grow the first complex 3D human tumour in the laboratory

Building a 3D model of ovarian cancer

Human cancers are more than just malignant cells, even at their very beginning. Other cells and chemicals that normally support and protect the body are hijacked by the cancer cells, instead helping the cancer to grow and spread.

Recent research has shown us the importance of targeting not only the malignant cancer cells but also this wider tumour microenvironment for long-term cancer treatment.

In the CANBUILD project, the multi-disciplinary team of scientists will be using the latest advances in tissue engineering, biomechanics, imaging and stem cell biology. They believe this combination will make it possible to engineer, for the first time, a complex 3D human tumour in which the different cell types making up the tumour microenvironment could communicate, evolve and grow in vitro (outside the body, in the laboratory).

The CANBUILD goal is to recreate the tumour microenvironment found in high-grade human ovarian cancer; the subtype that leads to 70 per cent of all ovarian cancer deaths. However, the research may have implications for several other cancer types as well.

The vision is that this project will replace traditional techniques in which human cancer cells are grown in isolation on plastic surfaces. Success in the CANBUILD project may also provide better ways of testing new drugs that target the human tumour microenvironment.

Professor Fran Balkwill, from Barts Cancer Institute, is Principal Investigator on the CANBUILD project. Professor Balkwill said:

“About half the cells in a tumour are not cancer cells, but ‘healthy’ cells such as immune cells and fibroblasts, which the cancer is somehow corrupting to help it grow and spread.

“It seems logical that the best long-term treatments will come from combining both therapies that target the cancer cells with something aimed at the wider tumour microenvironment which, while not cancerous cells themselves, are supporting the cancer’s growth.

“Growing an in vitro model, which contains all these types of cells, will allow us to watch how the cells communicate and how the tumour grows, teaching us more about what is going on in this complex system and hopefully giving us a model we can test new drugs on.”

The five-year research plan involves:

  • ‘Deconstruction’ of the human ovarian cancer tumour microenvironment
  • Constructing the artificial scaffold, optimising growth of different cell types, and assembling the model
  • Comparing the model to fresh human tissue
  • Investigating the roles of individual cells
  • Testing new treatments that target the tumour microenvironment
  • The ERC funding will also allow the team to communicate their research via the Centre of the Cell, Queen Mary’s award-winning science education centre and online resource, widening participation and outreach.

    Story Source:

    The above story is based on materials provided by Barts Cancer Institute.

    Share14Tweet9Share2ShareShareShare2

    Related Posts

    Final Clinical Trial Results Published for Advanced Kidney Cancer Therapy

    Final Clinical Trial Results Published for Advanced Kidney Cancer Therapy

    August 1, 2025
    New Study Uncovers Role of Mysterious Variants in Colon Cancer-Linked Gene

    New Study Uncovers Role of Mysterious Variants in Colon Cancer-Linked Gene

    August 1, 2025

    Proteogenomic Study of Healthy vs. Cancerous Prostate Tissues Leveraging SILAC and Mutation Databases

    July 31, 2025

    CCNY Researchers Identify Possible Chemotherapy-Linked Cognitive Changes in Cancer Survivors

    July 31, 2025
    Please login to join discussion

    POPULAR NEWS

    • Blind to the Burn

      Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

      60 shares
      Share 24 Tweet 15
    • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

      46 shares
      Share 18 Tweet 12
    • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

      37 shares
      Share 15 Tweet 9
    • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

      35 shares
      Share 14 Tweet 9

    About

    We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

    Follow us

    Recent News

    New Reporting Guidelines Established for Chatbot Health Advice Studies

    Solar and Battery Cut Energy Costs, Boost Backup

    Mitra Bio Joins ARDD 2025 as Tier 3 Sponsor

    • Contact Us

    Bioengineer.org © Copyright 2023 All Rights Reserved.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    No Result
    View All Result
    • Homepages
      • Home Page 1
      • Home Page 2
    • News
    • National
    • Business
    • Health
    • Lifestyle
    • Science

    Bioengineer.org © Copyright 2023 All Rights Reserved.